Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Bahrami

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Virology|August 17, 2004
Change of tropism of SL3-2 murine leukemia virus, using random mutational librariesShervin Bahrami, Mogens Duch, Finn Skou Pedersen
Virology|March 3, 2007
Ligand presentation on a synthetic flexible hinge in Moloney murine leukemia virus SU supports entry via a heterologous receptorShervin Bahrami, Mogens Duch, Finn Skou Pedersen
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 18, 2021
Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health?Rossella Talotta, Shervin Bahrami, Magdalena Janina Laska
Gene|October 15, 2003
Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectorsShervin Bahrami, Thomas Jespersen, Finn Skou Pedersen, et al.
Virus Research|October 18, 2015
Immune suppressive activity of the influenza fusion peptideShervin Bahrami, Magdalena Janina Laska, Finn Skou Pedersen, et al.
Retrovirology|February 9, 2010
Coupling of receptor interference and a host-dependent post-binding entry deficiency in a gammaretroviral envelope proteinShervin Bahrami, Ditte Ejegod, Karina Dalsgaard Sørensen, et al.
Journal of Virology|July 20, 2012
Construction of a gammaretrovirus with a novel tropism and wild-type replication kinetics capable of using human APJ as entry receptorShervin Bahrami, Kristina Pagh, Ditte Ejegod, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2016
Human Endogenous Retroviral Genetic Element With Immunosuppressive Activity in Both Human Autoimmune Diseases and Experimental ArthritisMagdalena Janina Laska, Anne Troldborg, Ellen-Margrethe Hauge, et al.
Clinical Immunology (Orlando, Fla.)|March 24, 2018
Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease modelShervin Bahrami, Elzbieta Anna Gryz, Jonas Heilskov Graversen, et al.
Clinical Immunology (Orlando, Fla.)|July 29, 2022
Retroviral glycoprotein-mediated immune suppression via the potassium channel K<sub>Ca</sub>3.1 - A new strategy for amelioration of inflammatory bowel diseasesMagdalena J Laska, Jesper Bonnet Moeller, Jonas Heilskov Graversen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Virology|August 17, 2004
Change of tropism of SL3-2 murine leukemia virus, using random mutational librariesShervin Bahrami, Mogens Duch, Finn Skou Pedersen
Virology|March 3, 2007
Ligand presentation on a synthetic flexible hinge in Moloney murine leukemia virus SU supports entry via a heterologous receptorShervin Bahrami, Mogens Duch, Finn Skou Pedersen
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 18, 2021
Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health?Rossella Talotta, Shervin Bahrami, Magdalena Janina Laska
Gene|October 15, 2003
Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectorsShervin Bahrami, Thomas Jespersen, Finn Skou Pedersen, et al.
Virus Research|October 18, 2015
Immune suppressive activity of the influenza fusion peptideShervin Bahrami, Magdalena Janina Laska, Finn Skou Pedersen, et al.
Retrovirology|February 9, 2010
Coupling of receptor interference and a host-dependent post-binding entry deficiency in a gammaretroviral envelope proteinShervin Bahrami, Ditte Ejegod, Karina Dalsgaard Sørensen, et al.
Journal of Virology|July 20, 2012
Construction of a gammaretrovirus with a novel tropism and wild-type replication kinetics capable of using human APJ as entry receptorShervin Bahrami, Kristina Pagh, Ditte Ejegod, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2016
Human Endogenous Retroviral Genetic Element With Immunosuppressive Activity in Both Human Autoimmune Diseases and Experimental ArthritisMagdalena Janina Laska, Anne Troldborg, Ellen-Margrethe Hauge, et al.
Clinical Immunology (Orlando, Fla.)|March 24, 2018
Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease modelShervin Bahrami, Elzbieta Anna Gryz, Jonas Heilskov Graversen, et al.
Clinical Immunology (Orlando, Fla.)|July 29, 2022
Retroviral glycoprotein-mediated immune suppression via the potassium channel K<sub>Ca</sub>3.1 - A new strategy for amelioration of inflammatory bowel diseasesMagdalena J Laska, Jesper Bonnet Moeller, Jonas Heilskov Graversen, et al.
Pageof 2